Viyash buys Italian vet distributor for €17M
The €16.975M cash deal adds a direct sales platform in Italy's companion animal market. It's a strategic, not a financial, move for the mid-cap.
— 3 earlier stories on Viyash Scientific Ltd. →What's new
- Viyash's Irish subsidiary Alivira is acquiring all shares of BioForLife Italia, a Milan-based distributor of vet products for companion animals.
- The binding cash deal is worth €16.975M. BioForLife had ~€9M in sales in 2025.
- Closing is expected in three months, pending notification under Italy's Golden Power laws.
Why this matters
The deal is a tidy fit but a small one. It gives Viyash an instant front-end in Italy, a market it has targeted in Europe. Financially, the impact is minimal: the price is about 1.3% of its market cap, and the target's revenue is roughly 2.3% of Viyash's consolidated top line.
What we're watching
- The Italian government's Golden Power review. Foreign acquisitions can face conditions.
- Integration of BioForLife's sales team and customer base.
- The revenue contribution from Italy once the deal closes.
The full read
Viyash Scientific is paying €16.975 million cash for BioForLife Italia, a Milan-based distributor of vet products for companion animals. The target had €9 million in sales last year. Through its Irish subsidiary Alivira, Viyash gets an instant sales platform in Italy. The binding agreement should close in three months, pending Golden Power review. For Viyash, this is market penetration. The price is just 1.3% of its market cap, and the target's revenue is a fraction of the parent's. It's a small deal. But it's a deliberate one: Viyash is building a direct European front-end in a high-margin segment, one acquisition at a time.
Questions answered
- What is Viyash acquiring?
- A 100% stake in BioForLife Italia s.r.l., a Milan-based distributor of veterinary products for companion animals. The seller is not named in the filing.
- How significant is this deal for Viyash?
- Not very. The €16.975M price is about 1.3% of Viyash's market cap. The target's €9M annual revenue is approximately 2.3% of the parent's consolidated top line.
- Why is Viyash buying an Italian distributor?
- It adds a direct sales and distribution platform in Italy, giving Viyash immediate customer reach. The move aligns with the company's stated strategy to expand its companion animal business in Europe.
- What could delay the deal?
- Italy's Golden Power law. The acquisition requires notification to Italian authorities, who can review deals in strategic sectors. The filing expects this process to take three months.
Story so far
All notes on VIYASH →- 8 Jun 2026 · 12:41 PM IST Viyash buys Italian vet distributor for €17M
- today Viyash's Italian pet-care bid jumps 28% to ₹188 cr
- 17d ago Viyash Scientific posts record quarter, sets ₹800 cr EBITDA run-rate for FY27
- 18d ago Viyash Scientific targets ₹1,000 cr EBITDA in 2-3 years, pivots to companion animals